Home » Human Breast Cancer Stem Cell Triple Positive (ER, PR, Her2 positive)- Frozen Vial
Human Breast Cancer Stem Cell Triple Positive (ER, PR, Her2 positive)- Frozen Vial
Catalog Number : 36102-30
Availability : In Stock
Price : $550.00
 

Related Products


  • Description
  • Publication
  • Documents

Human Breast Cancer Stem Cell  Triple Positive (ER, PR, Her2 positive)- Frozen Vial

 Also Avaliable as:

T25 plated cells $550.00 shipped at room temperature. Cat# 36102-30-T25                             

T75 plated cells $750.00 shipped at room temperature. Cat# 36102-30-T75

120 Population doublings or up to 12 passages.

One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice.

This product would require pre-coated flasks with Human Breast Cancer Stem Cell Extra-cellular Matrix Cat# E36102-30 and Human Breast Cancer Stem Cell Media Cat# M36102-29

Cell Cultures from single donors, 1000 different cell cultures available, please indicate which lots you require from the 1000 donors.

Source: Human Breast Cancer tissue (Triple Positive: ER, PR and Her 2 Positive)

Positive Markers: CD133, CD44, SSEA3/4, Oct4, Tumorigenicity (<1000 cells), Alkaline Phosphatase, Aldehyde Dehydrogenase, Telomerase,ER+,PR+,Her2+

For non-academic use, please inquire for pricing.

Cells are only guaranteed with purchase of Celprogen Media and Celprogen Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment.

ELISA Characterization Kits:

CD44 - Human Breast CSC Characterization Kit - Cat# K36102-30A

Nestin - Human Breast CSC Characterization Kit - Cat# K36102-30B

Oct 3/4 - Human Breast CSC Characterization Kit - Cat# K36102-30C

SSEA 3/4 - Human Breast CSC Characterization Kit - Cat# K36102-30D

CD133 - Human Breast CSC Characterization Kit - Cat# K36102-30-E

 

1000 individual donors are fully characterized proprietary patient-derived xenografts (PDX) representing all major histotypes and capturing tumor diversity.

Subcutaneous, orthotopic and disseminated models.  Extensive molecular and pharmacological characterization as well as information on patients' pretreatment to help you select the most appropriate model.